LEVERONE JASON A. (Chief Financial Officer) sold 1.6% of their position (303.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0001692747-26-000003
Officer· Chief Financial Officer
Since Oct 2024
-303.00
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
303.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−303.00
Price / share
$4.40
Trade value
$1.33K
% of position
1.6%
6/22/2026
19.11K→18.80K
Total
Net shares
−303.00
Net value
-$1.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/22/2026 | S · Sale | −303.00 | $4.40 | $1.33K | 1.6% | 19.11K | 18.80K |
| Total | −303.00 | -$1.33K | ||||||
Derivative Transactions0
No derivative transactions reported